
UCLA researchers led by Dr. Owen Witte and Dr. @dinodicarlo have discovered three never-before-seen T-cell receptors for #ProstateCancer, a finding that could lead to new tumor-fighting #immunotherapies. ➡️ bit.ly/3JoHiON


UCLA researchers led by Dr. Owen Witte and Dr. @dinodicarlo have discovered three never-before-seen T-cell receptors for #ProstateCancer, a finding that could lead to new tumor-fighting #immunotherapies. ➡️ bit.ly/3JoHiON

We’re excited to welcome medical diagnostics veteran Christopher Slachta as Cytovale's COO. With 20+ years of experience in the industry, Slachta will lead operations as Cytovale ramps up production of the FDA-cleared IntelliSep sepsis test. bit.ly/3T56WfM

The path to understanding the mysteries of the cell takes innovative technology, lots of data & multi-institution collaboration. To reach this goal, we’re announcing 4 projects in genomics & #biology, uniting labs to decode cellular functions ⬇️


Join our team transforming biological discovery. We are looking for a Project Manager in coordinating an exciting new Biotechnology research program between UCLA, USC, and Caltech focused on Synthetic Morphogenesis and Lab on a Particle Technologies. linkedin.com/posts/dino-di-c…

@Cytovale is proud to announce our partnership with @BARDA under the DRIVe's Host-Based Diagnostics Program to evaluate the clinical impact of host-based diagnostics. medicalcountermeasures.gov/n… #Sepsis

New content online: Associating growth factor secretions and transcriptomes of single cells in nanovials using SEC-seq dlvr.it/T009Fw

Excited to travel to @SelectBio’s Lab-on-a-Chip World Congress for a special Microfluidics Symposium, organized by @dinodicarlo and @FolchLab in honor of Mehmet Toner’s 65th Birthday🍾🎉 Looking forward to seeing many friends and colleagues while also hearing about great science

Read more from General Partner Zack Scott about why we’re excited to partner with co-founders Ajay Shah and @dinodicarlo to bring this life-saving technology to more hospitals and health systems: nvp.com/blog/cytovale-a-brea…

Breaking News: Cytovale secures $84 Million in Series C funding to advance the commercialization of the transformative sepsis diagnostic tool, IntelliSep®. Read more here — ow.ly/e2Xl50Q7SmJ.

In this Nature Methods Paper (bit.ly/44HCah1), our TotalSeq oligo-barcoded antibodies support a new method called secretion-encoded cell sequencing to interrogate proteins and single-cell transcriptomes. Explore our TotalSeq (bit.ly/3XxYjfK) reagents. #Revvity

We are delighted to be sponsoring @SelectBio Lab-on-a-Chip & Microfluidics World Congress 2023 poster prizes! Chaired by @dinodicarlo, @FolchLab, @ALineInc's Leanna Levine & @ChipShop_Jena's Claudia Gärtner - the conference is happening 28 November - 30 November 2023

Exciting breakthrough! Using #nanovials, @ScienceRicker and @DinoDiCarlo's teams uncovered key genes tied to immunoglobulin G (IgG) production and release in their @NatureComms article. hubs.li/Q01-_RYQ0

A new study by @UCLA Prof. Dino Di Carlo @BioEngUCLA and the Seattle Children’s Research Institute @seattlechildren identifies genes linked to key antibody production that can improve cell therapies. @UCLAMechAeroEng @CNSIUCLA @UCLAJCCC samueli.ucla.edu/new-study-i…

Cytovale is honored to have a partner in Our Lady of the Lake Regional Medical Center!

It’s rare to be involved in a first in medicine. I am proud to announce that our team @ololhealth is the first hospital in the world to adopt the IntelliSep Sepsis test from @Cytovale with @LSUHealthNO. I am excited about how our team will be able to improve patient care for LA!